Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis-Reference-Cited by-同舟云学术

Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis

Published:2016-11-14 Issue: Volume: Page:jjw174
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:ECCOJC

Author:

Guirgis Marianne,Wendt Emily,Wang Lai Mun,Walsh Alissa,Burger Daniel,Bryant Robert V.,Kent Alex,Adamson Rebecca,Brain Oliver,Travis Simon P. L.,Keshav Satish

Funder

National Institute for Health Research

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/11/4/460/17682328/jjw174.pdf

Reference49 articles.

1. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

2. Review article: defining remission in ulcerative colitis

3. Looking beyond histological healing in ulcerative colitis: towards the establishment of a molecular signature for quiescent but progressive disease

4. Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis?

5. Bryant RV Burger DC Delo J . Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut 2016;65:408–14.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential of Molecular Remission: Tissue Neutrophil Elastase Is Better Than Histological Activity for Predicting Long-Term Relapse in Patients With Ulcerative Colitis in Endoscopic Remission;Inflammatory Bowel Diseases;2024-08-27

2. Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials;Expert Review of Gastroenterology & Hepatology;2024-03-03

3. Predictors of non-response to ongoing conservative therapy in patients with inflammatory bowel disease;Miscellaneous Considerations in Inflammatory Bowel Disease;2024-01-09

4. The Usefulness of Tissue Calprotectin in Pediatric Crohn’s Disease—A Pilot Study;Gastrointestinal Disorders;2023-01-12

5. Intramucosal Calprotectin Expression in Inflammatory Bowel Disease (IBD) and Non-IBD Colorectal Inflammation;Open Access Macedonian Journal of Medical Sciences;2022-04-08